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Research Article
Caspase-1 cleaves Bid to release mitochondrial SMAC and
drive secondary necrosis in the absence of GSDMD
Rosalie Heilig, Marisa Dilucca, Dave Boucher , Kaiwen W Chen , Dora Hancz, Benjamin Demarco , Kateryna Shkarina,
Petr Broz
Caspase-1 drives a lytic inflammatory cell death named pyroptosis
by cleaving the pore-forming cell death executor gasdermin-D
(GSDMD). Gsdmd deficiency, however, only delays cell lysis, in-
dicating that caspase-1 controls alternative cell death pathways.
Here, we show that in the absence of GSDMD, caspase-1 activates
apoptotic initiator and executioner caspases and triggers a rapid
progression into secondary necrosis. GSDMD-independent cell
death required direct caspase-1–driven truncation of Bid and
generation of caspase-3 p19/p12 by either caspase-8 or caspase-9.
tBid-induced mitochondrial outer membrane permeabilization
was also required to drive SMAC release and relieve inhibitor of
apoptosis protein inhibition of caspase-3, thereby allowing
caspase-3 auto-processing to the fully active p17/p12 form. Our
data reveal that cell lysis in inflammasome-activated Gsdmd-
deficient cells is caused by a synergistic effect of rapid caspase-
1–driven activation of initiator caspases-8/-9 and Bid cleavage,
resulting in an unusually fast activation of caspase-3 and im-
mediate transition into secondary necrosis. This pathway might
be advantageous for the host in counteracting pathogen-induced
inhibition of GSDMD but also has implications for the use of
GSDMD inhibitors in immune therapies for caspase-1–dependent
inflammatory disease.
DOI 10.26508/lsa.202000735 | Received 7 April 2020 | Revised 16 April
2020 | Accepted 16 April 2020 | Published online 28 April 2020
Introduction
Inflammasomes are cytosolic signalling platforms assembled after
the recognition of host- or pathogen-derived danger signals by
cytosolic pattern recognition receptors, such as pyrin, AIM2, and
members of the Nod like receptor (NLR) protein family (Broz & Dixit,
2016). These complexes serve as activation platforms for caspase-1,
the prototypical inflammatory caspase. Active caspase-1 cleaves
the pro-inflammatory cytokines IL-1β and IL-18 to their mature
bioactive form and induces a lytic form of cell death known as
pyroptosis, by processing the cell death executor gasdermin-D
(GSDMD) (Kayagaki et al, 2015; Shi et al, 2015). Caspase cleavage
at the residue D276 in mouse (D275 in human) removes the in-
hibitory GSDMDCT and allows GSDMDNT to translocate to cellular
membranes and form permeability pores, which disrupt ion ho-
meostasis and the electrochemical gradient (Kayagaki et al, 2015;
Shi et al, 2015; Aglietti et al, 2016; Ding et al, 2016; Liu et al, 2016;
Sborgi et al, 2016). GSDMD is also cleaved by caspase-11 in mice and
by caspase-4 and caspase-5 in humans, which are activated by the
so-called noncanonical inflammasome pathway in response to LPS
stemming from infections with cytosolic Gram-negative bacteria
(Kayagaki et al, 2011, 2013; Hagar et al, 2013; Shi et al, 2014). Un-
controlled inflammasome activation by gain-of-function mutations
in inflammasome receptors or in the context of sterile inflammatory
disease has been linked to a number of hereditary and acquired
inflammatory diseases, such as cryopyrin-associated periodic syn-
drome (Muckle–Wells syndrome), but also gout, Alzheimer’s disease,
and atherosclerosis (Masters et al, 2009). It is, thus, of high interest to
target and inhibit inflammasome assembly or downstream effector
processes such as GSDMD pore formation and IL-1β release.
Although Gsdmd deficiency results in complete abrogation of
caspase-11 (-4)–induced lytic cell death, it only delays caspase-
1–induced cell lysis (He et al, 2015; Kayagaki et al, 2015). Caspase-1
activation in Gsdmd−/− cells correlates with high levels of caspase-
3/7 and caspase-8 activity, but whether these apoptotic caspases
trigger lysis of Gsdmd-deficient cells after caspase-1 activation has
not been proven (He et al, 2015), and activation of apoptotic cas-
pases has been observed to occur even in inflammasome-activated
WT cells (Lamkanfi et al, 2008; Sagulenko et al, 2018). The lytic death
of Gsdmd−/− cells is also in contrast to the notion that apoptosis is
non-lytic and, thus, immunologically silent. However, it is also
known that prolonged apoptotic caspase activity will result in
apoptotic cells losing membrane integrity, a process termed
“secondary necrosis.” Apoptosis is executed by caspase-3/-7, which
themselves are activated by either caspase-8 (extrinsic apoptosis
pathway) or caspase-9 (intrinsic or mitochondrial apoptosis
pathway). Ligation of death receptors at the plasma membrane
(FasR, tumor necrosis factor receptor, and Trail) results in the
assembly of the death-inducing signalling complex or tumor ne-
crosis factor receptor complex IIa/b, which activates caspase-8, the
initiator caspase of the extrinsic pathway. In type-I cells, caspase-8
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activity is sufficient to activate the executioner caspases, whereas
in type-II cells, caspase-8 requires activation of the intrinsic
pathway in addition (Jost et al, 2009). Here, caspase-8 cleaves the
Bcl-2 family protein Bid to generate a truncated version (tBid),
which triggers Bax/Bak–induced mitochondrial outer membrane
permeabilization (MOMP). MOMP results in the release of second
mitochondria-derived activator of caspases (SMAC), ATP, and cyto-
chrome c to promote intrinsic apoptosis via formation of the apop-
tosome. This complex consists of apoptotic protease-activating factor 1
(APAF1), cytochrome c, ATP, and caspase-9 and serves as an activation
platform for caspase-9, which in turn cleaves caspase-3. Apoptosis is a
tightly regulated process, and disturbance of the equilibrium of cy-
tosolic pool of pro- and anti-apoptotic Bcl-2 family proteins can result
in MOMP, apoptosis induction, and cell death (Riley, 2018; Vince et al,
2018). To prevent accidental activation of apoptosis, inhibitor of ap-
optosis proteins (IAPs), in particular X-linked inhibitor of apoptosis
protein (XIAP), suppresses caspase-3/7 and caspase-9 activation by
direct binding to the caspases via baculovirus IAP repeat (BIR) domains
(Roy et al, 1997; Takahashi et al, 1998; Bratton et al, 2002; Scott et al,
2005). SMAC, which is released during MOMP, antagonizes IAPs, thus
removing the brake on caspase auto-processing and allowing full
activity of the executioner caspases and apoptotic cell death (Du et al,
2000; Verhagen et al, 2000; Wilkinson et al, 2004).
Here, we investigate the mechanism that induces lytic cell death
after caspase-1 activation in Gsdmd-deficient cells. We show that cell
death in Gsdmd−/− macrophages requires caspase-1, Bid-dependent
mitochondrial permeabilization, and the executioner caspase-3. Re-
markably, Gsdmd-deficient cells form apoptotic blebs and bodies only
transiently, before shifting rapidly to a necrotic phenotype that is
characterized by extensive membrane ballooning. Unexpectedly, we
found that Bid cleavage and subsequent MOMP is driven directly by
caspase-1 independently of caspase-8, although high levels of cleaved
caspase-8 p18 are found in inflammasome-activated Gsdmd-deficient
cells. Upon investigating the steps downstream of MOMP, we observed
that knocking-out Casp9 in Gsdmd−/− cells had only a small effect on cell
death, whereas removing both Casp8 and Casp9 abrogated GSDMD-
independent cell death. The redundancy in caspase-8 and caspase-9
requirement was explained by the observation that either caspase was
sufficient to process caspase-3 between the large and small catalytic
domains, thereby generating the intermediate caspase-3 p19 and p12
fragments. Caspase-1–dependentBid cleavageandSMAC releaseare then
required to remove IAP inhibition, thereby allowing auto-cleavage of
caspase-3 to the p17/p12 fragments and full caspase activation (Kavanagh
et al, 2014). Thus, cell lysis in the absence of GSDMD is driven by the
synergistic effect of both rapid caspase-1–driven activation of initiator
caspases-8/-9 and Bid cleavage, which results in an unusually fast ac-
tivation of caspase-3 and immediate transition into secondary necrosis.
Results
Canonical inflammasomes trigger a rapid secondary necrosis in
the absence of GSDMD
The canonical and noncanonical inflammasome pathways con-
verge on the caspase-dependent cleavage and activation of the
pyroptosis executor GSDMD (Kayagaki et al, 2015; Shi et al, 2015).
However, although GSDMD is essential for lytic cell death (pyrop-
tosis) after LPS-induced noncanonical inflammasome activation
(Fig S1A), Gsdmd deficiency only delays cell lysis after engagement
of canonical inflammasome receptors, such as AIM2 (Figs 1A and
S1B–D), NLRC4, and NLRP3 (Figs 1A and S1B–D) (Kayagaki et al, 2015).
The absence of caspase-1 and caspase-11 in primary BMDMs, by
contrast, showed a much stronger reduction in lactate dehydro-
genase (LDH) release and propidium iodide (PI) influx, and Asc
deficiency completely abrogated cell lysis after AIM2 or NLRP3
activation, in line with the reported Apoptosis-associated speck-
like protein containing a CARD (ASC)-dependent activation of
apoptosis in absence of caspase-1 (Pierini et al, 2012; Man et al,
2013; Sagulenko et al, 2013; Chen et al, 2015; Vajjhala et al, 2015).
We next tested a number of cell death inhibitors for their ability
to block cell lysis in Gsdmd−/− immortalized BMDMs (iBMDMs)
transfected with poly(dA:dT), an activator of the AIM2 inflamma-
some (Fig S2). Neither 7-Cl-O-Nec1 (RIPK1 kinase inhibitor) nor
GSK872 (RIPK3 kinase inhibitor) were able to delay cell death in
Gsdmd−/− iBMDMs, thereby excluding a role for necroptosis or
complex IIb-dependent apoptosis, which require the kinase activity
of RIPK3 or RIPK1, respectively (Cho et al, 2009; He et al, 2009; Zhang
et al, 2009; Feoktistova et al, 2011; Tenev et al, 2011). Similarly, we
ruled out the involvement of calpains, calcium-dependent proteases
(PD 150606 and Calpeptin), or cathepsins (pan-cathepsin inhibitor
K777), which were previously shown to induce apoptosis through a
caspase-3–dependent or caspase-3–independent mechanisms
(Stennicke et al, 1998; Chwieralski et al, 2006; Momeni, 2011). Finally,
we also tested if caspase inhibitors delayed death in Gsdmd−/− or WT
iBMDMs. Remarkably, we found that whereas the pan-caspase
inhibitor VX765 delayed PI uptake in both WT and Gsdmd−/−
poly(dA:dT) transfected cells, the specific caspase-3/-7 inhibitor I
only blocked cell death in Gsdmd−/− but not in WT cells (Figs 1B
and S2). VX765 failed to prevent cell death in WT cells at later time
points in accordance with previous studies that showed pyrop-
tosis is difficult to block pharmaceutically (Schneider et al, 2017).
Although this suggested that apoptotic executioner caspases
were necessary for cell death in Gsdmd-deficient cells but dis-
pensable for cell death in WT cells, the speed by which Gsdmd-
deficient cells underwent apoptosis and subsequently cell lysis was
remarkable. Gsdmd−/− BMDMs displayed DNA laddering and pro-
cessing of caspase-3 to the mature p17 fragment within 1 h after
poly(dA:dT) transfection, which was faster than even the highest
concentrations of either extrinsic or intrinsic apoptosis stimuli
tested (Fig 1C and D). It is noteworthy that the highest concentration
regularly used to induce apoptosis is yet 20 times lower than the
concentration used in our study (Vince et al, 2018). Phenotypically,
this rapid activation of caspase-3 resulted in a very fast lytic cell
death as measured by PI influx (Fig 1E) and morphological analysis
(Fig 1F). Of note, inflammasome-stimulated Gsdmd−/− BMDMs ini-
tiated membrane blebbing and apoptotic body formation initially,
but rapidly lost this morphology and transitioned into a necrotic
state, characterized by extensive membrane ballooning (Fig 1F),
similarly to the end-stage of GSDMD-induced pyroptosis (Fig
S3A–C). We conclude that inflammasome activation in the ab-
sence of GSDMD results in rapid cell lysis, which we propose to refer
to as “GSDMD-independent secondary necrosis” to reflect both the
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Figure 1. Canonical inflammasome activation Gsdmd-deficient macrophages results in rapid secondary necrosis.
(A, B) LDH release, PI influx, and IL-1β release from LPS-primedWT, Asc−/−, Casp1−/−/Casp11−/−, and Gsdmd−/− primary or immortalized BMDMs (BMDMs and iBMDMs) after
transfection of poly(dA:dT) in the absence or presence of the indicated inhibitors. (C, D, E) DNA cleavage, PI influx, and immunoblots showing caspase-3/-7 processing
from LPS-primed Gsdmd−/− BMDMs transfected with poly(dA:dT) or treated with 100 ng/ml TNF-α plus 10, 5, or 1 μM AZD5582 (extrinsic apoptosis) or 1 μM ABT-737 plus 10, 1,
or 0.5 μMS63845 (intrinsic apoptosis). (F) Confocal images of LPS-primed Gsdmd−/− BMDMs transfected with poly(dA:dT) or left untreated and stained with CellTox Green
(green). Scale bar = 10 μM. Graphs show mean ± SD. Data and blot are representative of at least three independent experiments.
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rapid transition to the necrotic state and the requirement for the
activity of the apoptotic executioner caspases-3/-7.
GSDMD-independent secondary necrosis is mainly driven by
caspase-3
We next investigated which executioner caspase was required for
GSDMD-independent secondary necrosis after caspase-1 activa-
tion. High levels of caspase-3/-7 activity was detected in poly(dA:
dT)–transfected and Salmonella-infected Gsdmd−/− and to a lesser
degree in Casp1−/−/Casp11−/− BMDMs, whereas WT or Asc−/− BMDMs
showed minimal to no activity (Figs 2A and S4A). Because both
caspase-3 and caspase-7 cleave the DEVD peptidic substrate, we
next determined which executioner caspase was cleaved in
Gsdmd−/− cells but found that both caspase-3 and caspase-7 were
rapidly cleaved (Fig 2B). Although cleaved caspase-7 was detected
in both WT and Gsdmd-deficient cells, only Gsdmd−/− cells display
detectable caspase-3/-7 activity and caspase-3 cleavage (Fig 2A).
We, therefore, hypothesized that caspase-3 must account for the
DEVDase activity in Gsdmd−/− BMDMs.
To confirm our hypothesis genetically, we used CRISPR/Cas9
genome engineering to delete either Casp3 or Casp7, or both
Casp-3/7 in Gsdmd−/− BMDMs (Fig S4B) and determined the impact
of the deletion on GSDMD-independent secondary necrosis after
AIM2 inflammasome activation (Figs 2C and S4C). Gsdmd−/−/Casp3−/−
as well as Gsdmd−/−/Casp3−/−/Casp7−/− iBMDMs were strongly
protected against cell death after poly(dA:dT) transfection, whereas
Casp7 single deficiency did not provide protection, despite previous
reports that caspase-3 and caspase-7 function in a redundant
manner (Figs 2C and S4C) (Walsh et al, 2008; Lamkanfi& Kanneganti,
2010). Caspase-7 appeared to mainly contribute to the cell death
observed in Gsdmd−/−/Casp3−/− iBMDMs, as these had higher LDH
levels than Gsdmd−/−/Casp3−/−/Casp7−/− iBMDMs (Fig 2C). These
data were further corroborated by knockdown of caspase-3 or
caspase-7 in Gsdmd−/− iBMDMs (Fig S4D). Finally, we also examined
cell morphology after poly(dA:dT) transfection. Casp7 knockout in
Gsdmd−/− iBMDMs failed to reduce necrotic features and cell lysis,
whereas Gsdmd−/−/Casp3−/− and Gsdmd−/−/Casp3−/−/Casp7−/−
iBMDMs remained alive and intact (Fig 2D) at 3 h posttreatment. In
summary, these results demonstrate that although both execu-
tioner caspases are cleaved during cell death, it is caspase-3 that
drives GSDMD-independent secondary necrosis in inflammasome-
activated cells.
Because caspase-3 was shown to cleave gasdermin-E (GSDME),
another member of the gasdermin family, and GSDME was pro-
posed to drive secondary necrosis during prolonged apoptosis, we
asked whether lack of GSDMD drives an alternative cell death
pathway via caspase-3–mediated GSDME cleavage and pore for-
mation. We, thus, measured LDH release and PI influx in WT,
Gsdmd−/−, Gsdme−/−, and Gsdmd−/−/Gsdme−/− BMDMs upon acti-
vation of the AIM2 inflammasome (Figs 2E and S5A). Surprisingly,
although GSDME was cleaved in Gsdmd−/− at 1 h post-poly(dA:dT)
transfection, we did not find a contribution of GSDME to cell death
in Gsdmd−/− BMDMs because double Gsdmd/Gsdme-deficiency did
not confer any additional protection (Figs 2E and S5A and B).
Furthermore, BMDMs lacking only GSDME were comparable with WT
BMDMs, overall suggesting that GSDME does neither contribute to
pyroptosis nor GSDMD-independent necrosis.
Caspase-1 is required to cause GSDMD-independent secondary
necrosis in inflammasome-activated cells
Because the ASC speck has been reported to control activation of
apoptotic caspases independently of caspase-1 (Lee et al, 2018;
Mascarenhas et al, 2017; Pierini et al, 2012; Sagulenko et al, 2013;
Schneider et al, 2017; Van Opdenbosch et al, 2017), we next gen-
erated Gsdmd−/−/Casp1−/− BMDMs to determine if caspase-1 was
required for GSDMD-independent secondary necrosis (Fig 3A).
Deletion of caspase-1 in Gsdmd-deficient BMDMs strongly reduced
LDH release, caspase-3 processing, and caspase-3 activity (Fig
3A–C). LDH levels after 3 and 5 h of poly(dA:dT) transfection were
comparable with Casp1−/−/Casp11−/− BMDMs, but not as low as in
Asc−/−, confirming that Casp1 deletion did not affect the cell death
that is caused through the ASC-Caspase-8 axis (Fig 3B). It would
theoretically be possible that GSDMD-independent secondary
necrosis is not driven by the catalytic activity of caspase-1, but by
the formation of a caspase-1–containing scaffold and the assembly
of an unknown death inducing complex, in analogy to the scaf-
folding function of caspase-8 (Henry & Martin, 2017). However, we
found that poly(dA:dT)–induced PI influx in BMDMs from Casp1C284A/
C284A mice, which express a catalytically dead caspase-1, was
comparable with Casp1−/−/Casp11−/− or Casp1−/− BMDMs, and much
lower than PI influx in Gsdmd−/−. We formally excluded this pos-
sibility (Fig 3D) and thus conclude that caspase-1 enzymatic activity
is required to drive GSDMD-independent secondary necrosis.
Bid cleavage is required for mitochondrial damage and GSDMD-
independent secondary necrosis
While examining the morphology of inflammasome-activated
BMDMs by confocal microscopy, we found that Gsdmd−/− cells
were characterized by mitochondrial fragmentation and loss of
mitochondrial membrane potential (Fig S6A) and a rapid drop of
cellular ATP levels (Figs 4A and S6B–D) as early as 30 min after
inflammasome activation. Given this rapid loss of mitochondrial
integrity, we hypothesized that it was linked to the rapid onset of
caspase-3 activation and induction of secondary necrosis in
Gsdmd-deficient cells.
An imbalance of pro- and anti-apoptotic Bcl2 family members
results in the activation of Bax/Bak pore formation and loss of
mitochondrial integrity during apoptosis. Often, degradation and/
or cleavage of anti-apoptotic Bcl2 proteins as well as activating
cleavage of BH3-only protein are responsible for MOMP. To identify
which pro-apoptotic Bcl2 proteins are processed in Gsdmd−/−
BMDMs, wemade use of Stable Isotope Labeling with Amino acids in
Cell culture (SILAC) mass spectrometry approach (Ong et al, 2002).
Differentially isotope-labelled immortalized Gsdmd−/− and Asc−/−
BMDMs were transfected with poly(dA:dT), proteins separated by
molecular weight using SDS–PAGE, cut according to MW and each
slice analysed by mass spectrometry (Slice-SILAC). The differential
analysis of the heavy versus light fraction enabled a comparison
between the nonresponsive Asc−/− and the responsive Gsdmd−/−,
wherein appearance of smaller fragments in Gsdmd−/− indicated
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Figure 2. Caspase-3 drives GSDMD-independent secondary necrosis in inflammasome activated cells.
(A, B) LDH release, caspase-3/-7 activity (DEVDase activity) and immunoblots showing caspase-3/-7 processing from LPS-primed WT, Asc−/−, Casp1−/−/Casp11−/−, and
Gsdmd−/− primary BMDMs after transfection of poly(dA:dT). (C) LDH release from LPS-primedWT, Asc−/−, Casp1−/−/Casp11−/−, Gsdmd−/−, Gsdmd−/−/Casp3−/−, Gsdmd−/−/Casp7−/−,
and Gsdmd−/−/Casp3−/−/Casp7−/− iBMDMs after transfection of poly(dA:dT). (C, D) Confocal images of cells from (C). Insets show membrane ballooning in dying cells at 3 h
post-transfection. Scale bar = 10 μm. (E) Quantification of LDH release in LPS primed WT, Asc−/−, Casp-1−/−/Casp-11−/−, Gsdmd−/−, Gsdme−/−, and Gsdmd−/−/Gsdme−/−
BMDMs transfected with poly(dA:dT) for 4 h. Graphs show mean ± SD. **P ≤ 0.01, ***P ≤ 0.001, “ns,” no significance (unpaired t test). Data and blot are representative of at
least three independent experiments.
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cleavage. We focused on potential cleavage of Bcl-2 family proteins
that indicate their inability to inhibit BH3-only proteins or promote
BH3-only proteins to induce MOMP (Bock & Tait, 2019). The anti-
apoptotic protein Mcl-1 (of Bcl-2, Mcl-1, and Bcl-XL) and the pro-
apoptotic proteins Bax, Bak, and Bid (but not Bim) were found to be
cleaved in Gsdmd−/−, but not in Asc−/− cells (Fig 4B). Because in type-
II cells, caspase-8–cleaved tBid translocates to the mitochondria to
promote Bax/Bak–dependent pore formation and intrinsic apo-
ptosis, we investigated whether Bid cleavage promoted GSDMD-
independent secondary necrosis. Confirming the SILAC data, Bid
was found to be rapidly cleaved in Gsdmd−/− cells but not in Asc−/−
after inflammasome activation (Fig 4C). However, because Bid
cleavage was also observed in WT and Casp1−/−/Casp11−/− BMDMs,
we proceeded to assess its contribution to GSDMD-independent
secondary necrosis genetically by generating Gsdmd−/−/Bid−/−
iBMDMs (Fig S7A). Knocking out Bid in Gsdmd−/− cells significantly
reduced the levels of caspase-3 activity (Fig S7B) after poly(dA:dT)
transfection and in agreement with that strongly reduced LDH
release and PI uptake were observed (Figs 4D and S7C). Strikingly,
Gsdmd−/−/Bid−/− cells looked adhered and elongated comparable
Figure 3. Caspase-1 is required for GSDMD-
independent secondary necrosis.
(A, B, C) Immunoblot showing Caspase-1 expression
and caspase-3 processing, LDH release, and caspase-
3/-7 activity (DEVDase activity) from LPS-primed
Gsdmd−/− and Gsdmd−/−/Casp1−/− immortalized
BMDMs after transfection of poly(dA:dT). (D) PI influx of
WT, Asc−/−, Casp1−/−/Casp11−/−, Casp1−/−, Casp1C284A/C284A,
and Gsdmd−/− primary BMDMs after transfection of
poly(dA:dT). Graphs show mean ± SD. **P ≤ 0.01, ***P ≤
0.001, ****P ≤ 0.0001 (unpaired t test). Data and blot
are representative of at least three independent
experiments.
Figure 4. Mitochondrial damage is caused by
truncated Bid.
(A) LDH release and Titer-Glo measurements from LPS-
primed WT, Asc−/−, Casp1−/−/Casp11−/−, and Gsdmd−/−
primary BMDMs after transfection with poly(dA:dT).
(B) Schematic cleavage profile of Bcl-2 family members
generated from slice SILAC data. Bubble diameters are
proportional to the number of quantified peptide
matches, whereas the gradient color represents the H/
L ratio, as indicated below. The green bubbles (negative
log2H/L) represent protein isoforms reduced in
Gsdmd−/− iBMDMs compared with Asc−/− iBMDMs at 3 h
post-poly(dA:dT) transfection; red bubbles (positive
log2H/L) represent protein isoforms enriched in
Gsdmd−/− iBMDMs compared with Asc−/− iBMDMs. (C)
Immunoblots showing Bid processing from LPS-primed
WT, Asc−/−, Casp1−/−/Casp11−/−, and Gsdmd−/− primary
BMDMs after transfection with poly(dA:dT). (D) LDH
release from WT, Asc−/−, Casp1−/−/Casp11−/−, Gsdmd−/−,
and Gsdmd−/−/Bid−/− iBMDMs after transfection with
poly(dA:dT). Graphs show mean ± SD. *P ≤ 0.05, **P ≤
0.01, ****P ≤ 0.0001, “ns,” no significance (unpaired t
test). Data and blots are representative of at least
three independent experiments.
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with untreated iBMDMs upon transfection with poly(dA:dT), which is
in contrast to Gsdmd−/− iBMDMs which displayed typical necrotic
features such as rounding up, permeabilization, shrinkage, and
blebbing (Fig S7D). In summary, these results show that Bid is an
essential mediator of GSDMD-independent secondary necrosis and
suggest that Bid cleavage is required to drive this cell death.
Caspase-1 cleaves Bid to promote caspase-3 activation and cell
lysis
Because proteolytic cleavage of Bid precedes MOMP and is required
for cell death, we next enquired which upstream caspase is re-
sponsible for Bid activation. Immunoblotting for the cleaved p18
fragment of caspase-8 suggested that Gsdmd−/− BMDMs contain
active caspase-8 at 15–30 min after poly(dA:dT) transfection,
whereas very little cleaved caspase-8 p18 was found in WT, Asc−/−,
or Casp1−/−/Casp11−/− BMDMs (Figs 5A and S8A). Interestingly, the
relatively low levels of caspase-8 cleavage in Casp1−/−/Casp11−/−
compared with Gsdmd−/− BMDMs suggested that direct activation of
caspase-8 by the ASC speck was negligible and that instead
caspase-8 activation in Gsdmd−/− cells depended on the presence
caspase-1. However, whether caspase-1 would cleave and activate
caspase-8 directly or by an indirect pathway could not be deduced.
We next assessed the role of caspase-8 in causing GSDMD-
independent secondary necrosis by generating Gsdmd−/−/
Casp8−/− iBMDM lines (Fig S8B). Of note, although Casp8 defi-
ciency in mice results in embryonic lethality because of the un-
checked activation of RIP3-dependent necroptosis (Kaiser et al,
2011; Oberst et al, 2011), Casp8-deficient macrophages were re-
ported to be viable unless stimulated with extrinsic apoptotic
triggers (Kang et al, 2004; Kaiser et al, 2011; Cuda et al, 2015). Indeed,
when testing if Gsdmd−/−/Casp8−/− BMDMs showed reduced levels
of cell death after induction of apoptosis with the extrinsic
apoptosis stimulus TNFα/SMAC, we found that cell death was re-
duced, but not completely abrogated (Fig S8C). The remaining cell
death, however, was block when TNFα/SMAC was combined with
the RIPK3 kinase inhibitor GSK’872 (Fig S8C). These results confirmed
that the cells were indeed Casp8 knockouts and that the nec-
roptotic pathway was only initiated when death receptors were
engaged. Wenext compared LDH release inGsdmd−/− and Gsdmd−/−/
Casp8−/− BMDMs after transfection of the AIM2 inflammasome
activator poly(dA:dT). Unexpectedly, we found no difference in LDH
release nor PI uptake between these two genotypes (Figs 5B and
S8D). Furthermore, we were still able to detect Bid cleavage and
caspase-3 processing to the active p17 fragment in inflammasome-
activated Gsdmd−/−/Casp8−/− BMDMs (Fig 5C and D). Previous work
has implied that Bid can also be a substrate of caspase-1 (Li et al,
1998) because caspase-1 and caspase-8 have partially overlapping
substrate spectrum that includes also GSDMD and IL1β (Maelfait et
al, 2008; Orning et al, 2018; Sarhan et al, 2018; Chen et al, 2019). In line
with caspase-1 controlling Bid cleavage directly and independently
of caspase-8, we found that tBid generation after AIM2 activation
was completely abrogated in Gsdmd−/−/Casp1−/− BMDMs at an early
time point and strongly reduced after prolonged incubation (Fig 5E)
and that caspase-1 was able to efficiently convert Bid to tBid in an in
vitro cleavage assay (Fig 5F). In summary, our data thus far suggest
that although Bid cleavage is essential for GSDMD-independent
secondary necrosis and high levels of active caspase-8 are found in
these cells, it is caspase-1 and not caspase-8 that processes Bid
and induces mitochondrial permeabilization.
GSDMD-independent secondary necrosis requires both caspase-8
and caspase-9
Having identified caspase-1, Bid and caspase-3 as the essential drivers
of GSDMD-independent secondary necrosis, we next asked if activation
Figure 5. Caspase-1 drives Bid processing during
GSDMD-independent secondary necrosis.
(A) Immunoblots showing caspase-1, caspase-7,
caspase-3, caspase-8, and caspase-9 processing in WT,
Asc−/−, Casp1−/−/Casp11−/−, and Gsdmd−/− primary
BMDMs after transfection with poly(dA:dT). (B) LDH
release from WT, Asc−/−, Casp1−/−/Casp11−/−, Gsdmd−/−,
and Gsdmd−/−/Casp8−/− iBMDMs after transfection
with poly(dA:dT). (C) Immunoblots showing caspase-3
processing in Gsdmd−/− and Gsdmd−/−/Casp8−/−
iBMDMs after transfection with poly(dA:dT). (D)
Immunoblots showing Bid cleavage in Gsdmd−/− and
Gsdmd−/−/Casp8−/− iBMDMs after transfection with
poly(dA:dT). (E) Immunoblots showing Bid cleavage
in Gsdmd−/− and Gsdmd−/−/Casp1−/− iBMDMs after
transfection with poly(dA:dT). (F) In vitro cleavage assay
showing processing of recombinant Bid by
recombinant caspase-1. Graphs show mean ± SD. *
“ns,” no significance (unpaired t test). Data and blot are
representative of at least three independent
experiments.
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of caspase-9 downstream of mitochondrial permeabilization and cyto-
chromec release provides the link betweenBid and caspase-3 activation.
We, thus, generated Gsdmd−/−/Casp9−/− iBMDM lines by CRISPR/Cas9
genome targeting and verified that they lacked caspase-9 expressionand
no longer responded to intrinsic apoptosis induction (Fig S9A and B).
However, we found that in analogy to Casp8-deficiency, knocking out of
Casp9 in Gsdmd−/− had only a small impact on poly(dA:dT)–induced
secondary necrosis after 5 h of treatment, whereas no impact was de-
tectable at anearlier timepoint (Figs 6AandS9C). Furthermore, caspase-3
processing was also found to be unaffected in these cell lines (Fig 6B).
Figure 6. SMAC release and initiator caspases-8/-9
are required for GSDMD-independent secondary
necrosis.
(A) LDH release from WT, Asc−/−, Casp1−/−/Casp11−/−,
Gsdmd−/−, and Gsdmd−/−/Casp9−/− iBMDMs after
transfection with poly(dA:dT). (B) Immunoblots
showing caspase-3 cleavage in Gsdmd−/− and
Gsdmd−/−/Casp9−/− iBMDMs after transfection with
poly(dA:dT). (C) LDH release from WT, Asc−/−,
Casp1−/−/Casp11−/−, Gsdmd−/−, Gsdmd−/−/Casp8−/−,
Gsdmd−/−/Casp9−/−, and Gsdmd−/−/Casp8−/−/
Casp9−/− iBMDMs after transfection with poly(dA:dT).
(D) Immunoblots showing caspase-3 cleavage in
Gsdmd−/−, Gsdmd−/−/Casp8−/−, Gsdmd−/−/Casp9−/−,
and Gsdmd−/−/Casp8−/−/Casp9−/− iBMDMs after
transfection with poly(dA:dT). (E) Immunoblots showing
caspase-3 processing from Gsdmd−/− and Gsdmd−/−/
Bid−/− iBMDMs after transfection with poly(dA:dT).
(F) Schematic summary of the mechanism of caspase-3
cleavage and activation. (G) PI influx in untreated or
poly(dA:dT)–transfected Gsdmd−/−/Bid−/− iBMDMs in
the presence or absence of the SMAC mimetic AZD5582.
Graphs show mean ± SD. *P ≤ 0.05, **P ≤ 0.01
(unpaired t test). Data and blot are representative of at
least three independent experiments.
Figure 7. Model of cell death in Gsdmd-deficient
myeloid cells after activation of caspase-1.
Model depicting the mechanism of canonical
inflammasome activation in WT cells undergoing
caspase-1– and GSDMD-dependent pyroptosis and
Gsdmd−/− cells undergoing caspase-1–induced
GSDMD-independent secondary necrosis.
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These results raised the possibility that caspase-8 and caspase-
9 activity was redundant or that caspase-1 was driving Bid cleavage
and caspase-3 activation somehow independently of both initiator
caspases. We addressed these two scenarios by creating Gsdmd−/−/
Casp8−/−/Casp9−/− iBMDM lines (Fig S9D) and compared their
phenotype after AIM2 inflammasome activation to our other
knockout lines. Poly(dA:dT)–transfected Gsdmd−/−/Casp8−/−/
Casp9−/− BMDMs displayed significantly reduced levels of LDH re-
lease compared with Gsdmd−/−, Gsdmd−/−/Casp8−/−, or Gsdmd−/−/
Casp9−/− cells (Fig 6C). Consistent with the reduced levels of cell lysis, we
also found that caspase-3 processing was significantly reduced in
Gsdmd−/−/Casp8−/−/Casp9−/− when compared with the other genotypes
(Fig 6D), confirming that activity of either initiator caspasewas sufficient to
drive caspase-3 activation and GSDMD-independent secondary necrosis.
Bid-induced mitochondrial permeabilization is required to
release SMAC and promote conversion of caspase-3 p19 to p17
The finding that single deficiency in either caspase-8 or caspase-9
had no impact on caspase-3 activation and GSDMD-independent
secondary necrosis, whereas double-deficiency abrogated cell lysis
was unexpected and puzzling. Because Bid was essential for
GSDMD-independent secondary necrosis, whereas caspase-9 was
not, we hypothesized that other factors released from permeabilized
mitochondria were required. Besides cytochrome c, which activates
Apaf-1 to assemble the apoptosome and promote caspase-9 activity,
mitochondria also release ATP and SMAC. SMAC binds IAPs, in par-
ticular XIAP, which normally suppresses caspase-3/7 and caspase-9
activity, and thus relieves the block on apoptosis induction (Deveraux
et al, 1997; Wu et al, 2000). We, thus, closely examined caspase-3
processing between poly(dA:dT)–transfected Gsdmd−/− and Gsdmd−/−/
Bid−/− and found that while only the p17 fragment of caspase-3 was
found in Gsdmd−/− BMDMs, Gsdmd−/−/Bid−/− featured two cleaved
caspase-3 bands, at 19 and 17 kD (Figs 6E and S9E). Previous studies
showed that p19 fragment is generated by apical caspases cleaving in
the linker domain between the large and small subunit, whereas the
p17 is generated by auto-processing of the pro-peptide by caspase-3
itself (Kavanagh et al, 2014) (Fig 6F). We hypothesize that Bid defi-
ciency delayed IAP release and, thus, conversion from the p19 to the p17
fragment and full activity of caspase-3 and that this was a critical factor
for GSDMD-independent secondary necrosis. Indeed, treatment with
the SMAC mimetic AZD5582 increased generation of caspase-3 p17 (Fig
S9F) and partially restored cell death in Gsdmd−/−/Bid−/− BMDMs (Fig
6G). These results suggest that during GSDMD-independent secondary
necrosis, Bid cleavage and mitochondrial permeabilization are mainly
required for the release of SMAC and subsequent binding to XIAP but
not to drive caspase-9 activation. However, because either caspase-8 or
caspase-9 are needed to process caspase-3 (Fig 6D), caspase-1 cannot
induce GSDMD-independent secondary necrosis in the absence of both
initiator caspases (Fig 7).
Discussion
Here, we show that the cell lysis that occurs in Gsdmd-deficient
cells upon activation of canonical inflammasomes is a rapid form of
secondary necrosis (referred to as “GSDMD-independent secondary
necrosis” in this article) and that it depends on the caspase-1–
dependent activation of either caspase-8 or caspase-9, Bid
cleavage, SMAC release, and caspase-3 activity. Secondary necrosis
describes the loss of membrane integrity of apoptotic cells or
apoptotic bodies and is, thus, appropriate because death in
Gsdmd-deficient cells relies on initiator caspases and the executor
caspase-3 and results in a loss of membrane integrity. Yet, it is
remarkably different from regular apoptosis in the signalling
pathways that underlie its induction, cellular morphology, and the
speed by which cells undergo death.
GSDMD-independent cell lysis is characterized by a rapid loss of
mitochondrial potential and rapid activation of caspase-3 and an
atypical apoptotic morphology. Indeed, cells undergoing this type
of cell death show only initially the signs of regular apoptotic blebs
or apoptotic body formation and quickly lose membrane integrity
and start ballooning, similarly to pyroptotic cells. This morphology
has in the past led to the speculation that caspase-1 might directly
or indirectly cleave an alternative lytic cell death executor, such
as another gasdermin family member. Indeed, recently Tsuchiya
et al (2019) proposed that caspase-3 processes GSDME in Gsdmd-
deficient CL26 cells that harbor dimerizer-activated caspase-1
(Tsuchiya et al, 2019). Our data in primary mouse macrophages,
however, show no involvement of GSDME in GSDMD-independent
secondary necrosis (Figs 2E and S5A and B), although GSDME is
detectable and processed (Fig S5B). This discrepancy is most likely
caused by differences in GSDME expression levels between dif-
ferent cell types. Recent results show that a number of cancer cell
lines express sufficiently high levels of GSDME to cause pyroptosis
upon treatment with apoptosis-inducing chemotherapy drugs
(Wang et al, 2017b). It remains to be determined how much GSDME
is expressed by CL-26 cells, a murine colorectal carcinoma cell
line, compared with macrophages (Tsuchiya et al, 2019), but
overwhelming evidence suggest that at least in macrophages,
GSDME expression or activity appear to be insufficient to induce
GSDME-dependent cell death after caspase-3 activation (Lee et al,
2018; Sarhan et al, 2018; Vince et al, 2018; Chen et al, 2019). Thus,
other yet undefined factors drive the lysis of Gsdmd-deficient
BMDMs.
Another striking difference between regular apoptosis and
GSDMD-independent secondary necrosis is the signalling pathway
underlying caspase-3 activation. Our data show that themain driver
of this cell death is active caspase-1 and that it promotes cell death
by cleaving several targets. The most critical of these targets ap-
pears to be Bid, which is converted by caspase-1 to tBid (inde-
pendently of caspase-8) and which induces mitochondrial
permeabilization and the release of cytochrome c, ATP, and SMAC.
Moreover, caspase-1 acts as a kind of “super-initiator” caspase by
activating initiator caspases-8/-9. It is worth noting that caspase-8
activation is mostly driven by caspase-1 with a negligible contri-
bution of direct caspase-8 activation at the ASC speck, as evident
from much reduced caspase-8 cleavage in Casp1/Casp11–deficient
compared with Gsdmd-deficient cells. This could potentially be
driven by direct caspase-1–induced cleavage of caspase-8, or by
caspase-1, somehow enhancing ASC-dependent caspase-8 acti-
vation. Caspase-9 activation, however, is downstream of Bid
cleavage. The requirement for either caspase-8 and casoase-9
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appears to stem from the fact that caspase-1 fails to process
caspase-3 efficiently, despite previous reports suggesting that
caspase-1 cleaved caspase-3 directly (Taabazuing et al, 2017;
Sagulenko et al, 2018). However, caspase-1 is efficient enough to
activate Bid to induce SMAC release, to relieve inhibition by IAPs,
and allows full conversion to caspase-3 p17/p12.
Our findings are in contradiction to the recent report by the Suda
Laboratory, which proposed that cell death in Gsdmd-deficient cells
is solely caused by the Bid–caspase-9–caspase-3 axis (Tsuchiya et al,
2019). The discrepancy is potentially related to cell line–intrinsic
differences or to the method used to activate caspase-1. Tsuchiya et
al (2019) performed experiments in CL26 cells, which, for example,
lack ASC and, thus, lack the ASC speck-induced activation of caspase-
8 (Pierini et al, 2012; Sagulenko et al, 2013; Vajjhala et al, 2015; Fu et al,
2016), whereas we used immortalized macrophages, which recapit-
ulate the behavior of primary BMDMs. Furthermore, they used a
dimerizer-based system to activate caspase-1, which most likely
induces higher levels of caspase-1 activity compared with physio-
logical inflammasome triggers and, thus, might explain why Tsuchiya
et al (2019) did not observe a role for caspase-8, which we find
necessary to amplify caspase-1 activity after treatment with ca-
nonical inflammasome triggers. However, both studies agree that Bid
cleavage is essential for cell death in Gsdmd-deficient cells and that
Bid is cleaved by caspase-1 independently of caspase-8.
Recent work has revealed a surprisingly high level of redundancy
and cross talk between the apoptotic, necroptotic, and pyroptotic
cell death pathways. Interestingly, inmany cases, these pathways or
the cross talk are normally not detectable or only turned on when
another pathway is inhibited. For example, deletion of caspase-8 or
mutation of its auto-processing sites are known to result in acti-
vation of RIP3/MLKL-dependent necroptosis, a pathway that is
otherwise not observed, and catalytic-dead caspase-8 results in
activation of necroptosis and pyroptosis (Kaiser et al, 2011; Oberst
et al, 2011; Kang et al, 2018, Newton, 2019a; 2019b). It is assumed
that this redundancy developed as a defense mechanism to guard
against pathogen-induced inhibition of apoptosis, and accordingly
viral inhibitors of the three major cell death pathways have been
identified (Li & Stollar, 2004; Taxman et al, 2010; Nailwal & Chan,
2019), which highlights that necroptosis is not an artifact caused by
lack of caspase-8 activity. Similarly, it could be speculated that the
ability of caspase-1 to induce rapid secondary necrosis by acti-
vating apoptotic caspases might have developed as a safeguard
against viruses that inhibit GSDMD. Indeed, recently, the pathogenic
enterovirus 71, which is known to trigger the NLRP3 inflammasome
(Wang et al, 2017a), was shown to interfere with GSDMD activation. In
particular, the viral protease 3C was shown to cleave GSDMD at
Q193/194, interfering with N-terminal fragment formation, oligo-
merization, and GSDMD pore formation (Wang et al, 2015). Fur-
thermore, GSDMD-independent secondary necrosis appears to
contribute to the clearance of bacterial infection, as it could be
shown that Gsdmd−/− mice are less susceptible to infection with
Francisella novicida compared with Casp1- or Aim2-deficient ani-
mals (Schneider et al, 2017; Kanneganti et al, 2018b). Along the same
lines, Gsdmd-deficient mice infected with Burkholderia thai-
landensis show lower CFUs and lower IL-1β levels than Casp1/
Casp11–deficient animals (Wang et al, 2019). Similarly, it was re-
ported that peritoneal IL-1β levels are higher in Salmonella
typhimurium–infected Gsdmd−/− mice than Casp1−/− controls
(Monteleone et al, 2018). These studies, thus, allow the conclusion
that GSDMD-independent cell death is also engaged in vivo and
that it allows partial protection against intracellular bacterial
pathogens. Unexpectedly, however, GSDMD-independent second-
ary necrosis does not appear to be important in models of auto-
inflammatory diseases because Gsdmd deficiency rescues mice
expressing mutant NLRP3 or Pyrin, linked to neonatal-onset mul-
tisystem inflammatory disease and familial Mediterranean fever
(Xiao et al, 2018; Kanneganti et al, 2018a).
Considering that knockout of GSDMD showed a big improvement in
pro-inflammatory symptoms associated with the autoinflammatory
diseases neonatal-onset multisystem inflammatory disease and fa-
milial Mediterranean fever and the importance of the canonical
inflammasome pathway in sterile inflammatory disease, research has
focused on the discovery of GSDMD-specific inhibitors. To date, several
inhibitors have been identified, although off-target effects and
specificity still need to be evaluated inmore detail (Rathkey et al, 2018;
Sollberger et al, 2018; Rashidi et al, 2019). Furthermore, it is important to
consider that caspase-1 activity is unrestrained by these inhibitors and
that, thus, caspase-1 might induce cell death and inflammation
through the back-up pathway described in our study.
Materials and Methods
Antibodies, chemicals, and reagents
Drugs
VX-765 (MedChemExpress), Caspase-3/7 inhibitor I (CAS 220509-74-
0; Santa Cruz Biotechnology), Q-VD-Oph (Selleck Chemicals),
AZD5582 (Selleck Chemicals), 7-Cl-O-Nec1 (Abcam), GSK872 (Selleck
Chemicals), K777 (AdipoGen), PD 150606 (Tocris), Calpeptin (Selleck
Chemicals), ABT-737 (Selleck Chemicals), S63845 (Selleck Chem-
icals), and Nigericin (InvivoGen).
Antibodies
GSDMD (Ab209845; Abcam), Casp-1 (Casper1, AG-20B-0042-C100;
AdipoGen), Tubulin (Ab40742; Abcam), IL-1β (AF-401-NA; R&D Sys-
tems), Caspase-3 (#9662; Cell Signaling Technology), Caspase-7
(#9492; Cell Signaling Technology), Caspase-8 (#9429 and 4927;
Cell Signaling Technology), Caspase-9 (#9508 and #9504; Cell Sig-
naling Technology), and Bid (#2003; Cell Signaling Technology).
Animal experiments
All experiments were performed with approval from the veterinary
office of the Canton de Vaud and according to the guidelines from
the Swiss animal protection law (license VD3257). C57BL/6J mice
were purchased from Janvier Labs and housed at specific
pathogen-free facility at the University of Lausanne. Mice lacking
Asc, Casp1, Casp1/11, Gsdmd, Gsdme, or expressing mutant
Casp1C284A have been previously described (Mariathasan et al, 2004;
Kayagaki et al, 2011; Schneider et al, 2017; Chen et al, 2019). All mice
were either generated (Gsdmd−/− and Gsdme−/−) or backcrossed
(other lines) in the C56BL/6J background.
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Cell culture and immortalization of macrophages
Primary mouse macrophages (BMDMs) were differentiated for 6 d and
cultured for up to 9 d in DMEM (Gibco) supplemented with 10% FCS
(Bioconcept), 20% 3T3 supernatant (MCSF), 10%Hepes (Gibco), and 10%
nonessential amino acids (Gibco). Immortalization of macrophages
was performed as previously described (Blasi et al, 1985; Broz et al,
2010). Immortalized macrophages (iBMDMs) were cultured in DMEM
complemented with 10% FCS (Bioconcept), 10% MCSF (3T3 superna-
tant), 10% Hepes (Amimed), and 10% nonessential amino acids (Life
Technologies). To passage the BMDMs and iBMDMs, the cells were
washedwith PBS and left to detach at 4°C for 15min and scarped using
cell scrapers (Sarstedt), spun down at 300g for 5 min at 4°C, and
resuspended in the appropriate amount of medium.
Crispr genome editing in immortalized macrophages
Bid-, Casp9-, Casp-8-, Casp-8/Casp9-, Casp1-, Casp3-, Casp7-, and
Casp3/7-deficient iBMDMs were generated using the genome-
editing system Alt-R-CRISPR/Cas (IDT) according to the manufac-
turer’s protocol. Briefly, the gene-specific targeting crRNA (Bid:
TGGCTGTACTCGCCAAGAGC TGG Caspase-9: CACACGCACGGGCTCCAACT
TGG, Caspase-8: CTTCCTAGACTGCAACCGAG AGG, Caspase-1: AAT-
GAAGACTGCTACCTGGC AGG, Caspase-7: GATAAG TGGGCACTCGGTCC
TGG, and Caspase-3: AATGTCATCTCGCTCTGGTA CGG or TGGGCC-
TGAAATACCAAGTC AGG) was mixed with the universal RNA oligo
tracrRNA to form a gRNA complex (crRNA–tracrRNA). The addition of
the recombinant Cas9 nuclease V3 allowed the formation of an RNP
complex specific for targeting the desired genes. The tracrRNA only
or RNP complexes were subsequently reverse transfected into
either WT or Gsdmd−/− immortalized iBMDMs using RNAiMax
(Invitrogen). The bulk population was tested for successful gene
mutation using the T7 endonuclease digestion assay as follows: the
cells were lysed by the KAPA Biosystems Kit according to the
manufacturer’s protocol, and genomic DNA flanking the guide RNA
(crRNA)–binding site was amplified by PCR using gene-specific
primers (Bid: fw: CTGGACATTACTGGGGGCAG, rv: CTCGATAGCCC-
CTTGGTGTC; Caspase-9: fw: CAAGCTCTCCAGACCTGACC, rv: GAGATCT-
GACGGGCACCATT; Caspase-8: fw: GGGATGTTGGAGGAAGGCAA, rv:
GGCACAGACTTTGAGGGGTT; Caspase-1: fw: CAGACAAGATCCTGAGGGCA,
rv: AGATGAGGATCCAGCGAGTAT; Caspase-7: fw: TTGCCTGACCCAAGGTTTGT,
rv: CCCAGCAACAGGAAAGCAAC; and Caspase-3: fw: GTG GGGGA-
TATCGCTGTCAT, rv: TGTGTAAGGATGCGGACTGC). The amplified genomic
DNA was used to perform the heteroduplex analysis according to the
manufacturer’s protocol (IDT). Single clones were derived from the
bulk population by limiting dilution, and the absence of protein
expression in single clones was verified by immunoblotting and
sequencing of genomic regions, where required.
siRNA knockdown
2.5 × 105 Gsdmd-deficient iBMDMs were seeded per well of a six-well
plate and incubated overnight. For the siRNA transfection, the
medium was changed to OptiMEM, and siRNA transfection was
carried out according to the manufacturer’s protocol, transfecting
25 pmol siRNA (non-targeting: siGENOME non-targeting siRNA
control pools [D-001206-14; Dharmacon], caspase-3: Casp3 SMART
POOL [M-043042-01; Dharmacon], and caspase-7: Casp7 SMART
POOL [M-057362-01; Dharmacon]) with 7.5 μl Lipofectamine RNAiMax
(Invitrogen) per well. Medium was exchanged for DMEM (10% FCS,
10% MCSF, 1% NeAA, and 1% Hepes) after 6 h. 48 h post-transfection,
the cells were collected and reseeded in a 96-well plate at 3 × 104
cells/well. The cells were primed and treated as in cell death
assays.
Cell death assays
The cells were seeded in 96-well plates (100 μl/well) or 12-well
plates (1 ml/well) at a density of 0.5 × 106 cells/ml overnight and
primed the next day with 100 ng/ml ultrapure LPS-B5 (055:B5;
InvivoGen) for 4 h. AIM2 inflammasome activation was achieved by
transfecting 0.4 μg poly(dA:dT) (InvivoGen) per 105 cells. In sep-
arate tubes, poly(dA:dT) and linear polyethylenimine (1 μg per 105
cells; PolyScience) were mixed with OptiMEM by vortexing and left
for 3 min at room temperature. Then poly(dA:dT) and poly-
ethylenimine (PEI) were mixed together, vortexed shortly, and left
for 15 min before adding a quarter of the total volume on top of
the cells. Transfection was facilitated by spinning cells for 5 min at
300g at 37°C. Salmonella enterica serovar Typhimurium SL1344
and Francisella tularensis subsp. novicida U112 (F. novicida) in-
fection were performed in OptiMEM. For S. typhimurium infection,
bacteria were grown overnight and subcultured 1/40 for 3 h and 30
min in Luria low-salt broth (LB low salt) supplemented with ap-
propriate antibiotics, whereas infection with Francisella were
performed from the overnight culture grown in brain heart in-
fusion broth supplemented with 0.2% L-cysteine (Sigma-Aldrich)
and appropriate antibiotics. Bacteria were then added on top of
the cells in OptiMEM, spun at 300g for 5 min and incubated at 37°C
for the duration of the experiment or extracellular bacterial
growth suppressed by addition of gentamycin at 30 and 120 min
postinfection for S. typhimurium, and F. novicida, respectively. For
the NLRP3 inflammasome activation, LPS-B5 (055:B5; InvivoGen)
priming was carried out in OptiMEM for 4 h before addition of 5 μM
nigericin (Sigma-Aldrich) and incubated for indicated time.
Similarly, the cells were primed with 100 ng/ml LPS LPS-B5 (055:B5;
InvivoGen) for 4 h in OptiMEM. LPS/FuGeneHD complexes were
prepared by mixing 100 μl OptiMEM with 2 μg ultrapure LPS O111:B4
(InvivoGen) and 0.5 μl of FuGENE HD (Sigma-Aldrich) per well to be
transfected. The transfection mixture was vortexed briefly, incu-
bated for 10 min at room temperature, and added dropwise to the
cells. The plates were centrifuged for 5 min at 200g and 37°C.
Extrinsic apoptosis was induced by adding 100 ng/ml TNF-α and
the SMAC mimetic AZD5582 at the indicated concentration. In-
trinsic apoptosis was induced by addition of the BH3 mimetic
small molecule inhibitor ABT-737 in combination with the Mcl-1
inhibitor S63845 at the indicated concentrations.
Cell death and cytokine release measurement
Cell lysis was assessed by quantifying the amount of lactate
dehydrogenase in the cell supernatant using the LDH cytotoxicity
kit (Takara) according to the manufacturer’s instructions. To
measure cell permeabilization, propidium iodide (Thermo Fisher
Scientific) was added to the medium at 12.5 μg/ml and fluorescent
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emission measured by Cytation5 (Biotek) over time. LDH and PI
uptake were normalized to untreated control and 100% lysis.
Cytokine release into the supernatant in particular IL-1β was
measured by Elisa (Thermo Fisher Scientific) according to the
manufacturer’s instructions.
DNA fragmentation assay
DNA fragmentation during apoptosis and pyroptosis was assessed
by agarose gel electrophoresis as described before (Kasibhatla et
al, 2006). In brief, Gsdmd−/− BMDMs were seeded in a 12-well plate
and treated with apoptotic triggers or transfected with poly(dA:dT)
as described under Cell Death Assays section.
Cell lysis and immunoblotting
After treatment of cells, cell supernatant was collected and 1×
sample buffer (Thermo Fisher Scientific) complemented with 66
nM Tris, and 2% SDS was added to the cell lysate. The proteins of
the supernatant were precipitated on ice using an end concen-
tration of 4% TCA (wt/vol) for 30 min. Supernatant was then spun
down at 20,000g for 20 min at 4°C washed with 100% acetone and
centrifuged at 20,000g for 20 min at 4°C. The protein pellet was
air-dried and resuspended with the lysate. The samples were
boiled for 10 min at 70°C and separated by a 10% or 12% SDS page
gel. Transfer to the 0.2 μM Polyvinylidene fluoride (PVDF) mem-
branes was accomplished by Trans-Blot Turbo System. The
membranes were blocked with 5% milk in TBS-T and incubates
with the primary antibody for 2 h at RT or overnight. Membranes
were washed three times with TBS-T and HRP-coupled antibodies
added in 5% milk in TBST-T for 1 h. After washing, the membranes
were revealed by FUSION imager (VILBER) using Pierce ECL
Western Blotting Substrate (Thermo Fisher Scientific) or Pierce ECL
Plus Western Blotting Substrate (Thermo Fisher Scientific).
Live cell imaging
BMDMs or iBMDMs were seeded 5 × 104/well in eight-well tissue
culture–treated μ-Slides (iBidi) or 96-well Cell Culture Microplates,
μClear (Greiner Bio-One) overnight and primed the next day with
100 ng/ml LPS 055:B5 for 4 h. The AIM2 inflammasome was acti-
vated by transfection of poy(dA:dT) (see the Cell Death Assay
section). For time-lapse microscopy, cells were incubated with
CellTox Green (Promega) 1:10,000 and AnnexinV (BioLegend) at
500 ng/ml or for mitochondrial health assessment MitoTracker
Green and MitoTracker CMXRos were added to OptiMEM at a final
concentration of 125 nM. Images were taken every 5 min or every
15 min, respectively. Zeiss LSM800 point scanning confocal mi-
croscope equipped with 63× Plan-Apochromat NA 1.4 oil objec-
tive, Zeiss ESID detector module, LabTek heating/CO2 chamber,
and motorized scanning stage.
Slice-SILAC
Gsdmd- and Asc-deficient iBMDMs were grown in SILAC DMEM
(Thermo Fisher Scientific) medium supplemented with 10% dialyzed
FBS, 200 mg/ml proline, 150 mg/ml heavy or light lysine and 50 mg/
ml arginine, respectively. The cells were passaged five to six times
until 100% labelling was achieved. For the experiment, the cells
were seeded at 5 × 105/well in 12-well plates overnight and primed
the next day with 100 ng/ml LPS 055:B5 for 4 h. Poly(dA:dT)
transfection was then carried out as described under Cell Death
Assays section and plates incubated for 3 h. The cells were scraped
in OptiMEM, and proteins were precipitated by 4% TCA. The obtained
protein pellet was then resuspended in FASP buffer (4% SDS, 0.1 M
DTT, and 100 mM Tris, pH 7.5), heated for 5 min at 95°C, sonicated,
and cleared by 10-min centrifugation at 12,000g. Downstream
sample preparation, including SDS gel preparation, mass spec-
trometry, and data analysis have been described before (Di Micco et
al, 2016).
Caspase activity assay
Caspase-3/7 activity was either measured by luminescence using
the Caspase-Glo 3/7 (Promega) according to the manufacturer’s
protocol or by fluorescence. The caspase activity assay was per-
formed as follows using the fluorescent substrate N-acetyl-Asp-
Glu-Val-Asp-7-amido-4-trifluoromethylcoumarin (Sigma-Aldrich).
The cells were lysed directly in the medium by adding 5× lysis
buffer (250 mM Hepes, 25 mM CHAPS, and 25 mM DTT) and pipetting
up and down. 30 μl of lysed cells was incubated with 30 μl of 2×
assay buffer (40 mM Hepes, 200 mM NaCl, 2 mM EDTA, 0.2% CHAPS,
20% sucrose, and 20 mM DTT), and 50 μM final concentration of
substrate was taken in black opaque OptiPlate-96 (PerkinElmer)
and read at 400/505 at 37°C every 2 min for 10 min.
Metabolic activity—ATP content
Metabolic activity was measured by Titer-Glo (Promega) according
to the manufacturer’s protocol. In brief, cells plus 25 μl supernatant
were incubated with 25 μl Titer-Glo, shook for 2 min at 600 rpm, and
incubated for 10 min at room temperature before reading.
In vitro caspase cleavage assay
Active recombinant caspase-1 was purified as described before
(Sborgi et al, 2016). For the in vitro cleavage assay, cell lysate from
iGsdmd−/−/Casp-3−/−/Casp-7−/− was prepared as described before
(Boucher et al, 2012). Briefly, the cells were lysed in ice-cold buffer
(50 mM Hepes, pH 7.4, 150 mM NaCl, and 1% IGEPAL) and incubated
on ice for 30min. Cellular proteins were recovered by centrifugation
at 7,000g for 10 min and kept at −80°C in 30-μl aliquots. Purified
active caspase-1 (50, 100 nM) was added to cell lysate and incu-
bated for 2 h at 37°C. The mixture was then analysed by
immunoblot.
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